| Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases R Willemze, PM Jansen, L Cerroni, E Berti, M Santucci, C Assaf, ... Blood, The Journal of the American Society of Hematology 111 (2), 838-845, 2008 | 743 | 2008 |
| Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United … EA Olsen, S Whittaker, YH Kim, M Duvic, HM Prince, SR Lessin, GS Wood, ... Journal of Clinical Oncology 29 (18), 2598-2607, 2011 | 683 | 2011 |
| La naturaleza colonizada: ecología política y minería en América Latina H Alimonda Ediciones Ciccus, 2011 | 661 | 2011 |
| Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study EJ Tarín-Vicente, A Alemany, M Agud-Dios, M Ubals, C Suñer, A Antón, ... The Lancet 400 (10353), 661-669, 2022 | 572 | 2022 |
| Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial HM Prince, YH Kim, SM Horwitz, R Dummer, J Scarisbrick, P Quaglino, ... The Lancet 390 (10094), 555-566, 2017 | 569 | 2017 |
| Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial YH Kim, M Bagot, L Pinter-Brown, AH Rook, P Porcu, SM Horwitz, ... The lancet oncology 19 (9), 1192-1204, 2018 | 564 | 2018 |
| EORTC consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome F Trautinger, R Knobler, R Willemze, K Peris, R Stadler, L Laroche, ... European journal of cancer 42 (8), 1014-1030, 2006 | 561 | 2006 |
| Gene expression profiling of primary cutaneous melanoma and clinical outcome V Winnepenninckx, V Lazar, S Michiels, P Dessen, M Stas, SR Alonso, ... Journal of the National Cancer Institute 98 (7), 472-482, 2006 | 555 | 2006 |
| European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides/Sézary syndrome–Update 2017 F Trautinger, J Eder, C Assaf, M Bagot, A Cozzio, R Dummer, R Gniadecki, ... European journal of cancer 77, 57-74, 2017 | 552 | 2017 |
| EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary … W Kempf, K Pfaltz, MH Vermeer, A Cozzio, PL Ortiz-Romero, M Bagot, ... Blood, The Journal of the American Society of Hematology 118 (15), 4024-4035, 2011 | 484 | 2011 |
| Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and Sézary syndrome: effect of specific prognostic markers on survival and … JJ Scarisbrick, HM Prince, MH Vermeer, P Quaglino, S Horwitz, P Porcu, ... Journal of Clinical Oncology 33 (32), 3766-3773, 2015 | 440 | 2015 |
| Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised … AMM Eggermont, CU Blank, M Mandalà, GV Long, VG Atkinson, S Dalle, ... The Lancet Oncology 22 (5), 643-654, 2021 | 333 | 2021 |
| PLCG1 mutations in cutaneous T-cell lymphomas JP Vaqué, G Gómez-López, V Monsálvez, I Varela, N Martínez, C Pérez, ... Blood, The Journal of the American Society of Hematology 123 (13), 2034-2043, 2014 | 233 | 2014 |
| Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells D Tormo, A Chęcińska, D Alonso-Curbelo, E Pérez-Guijarro, E Cañón, ... Cancer cell 16 (2), 103-114, 2009 | 232 | 2009 |
| The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients JJ Scarisbrick, P Quaglino, HM Prince, E Papadavid, E Hodak, M Bagot, ... British Journal of Dermatology 181 (2), 350-357, 2019 | 194 | 2019 |
| Panobinostat activity in both bexarotene-exposed and-naive patients with refractory cutaneous T-cell lymphoma: results of a phase II trial M Duvic, R Dummer, JC Becker, N Poulalhon, PO Romero, MG Bernengo, ... European journal of cancer 49 (2), 386-394, 2013 | 157 | 2013 |
| Blood classification and blood response criteria in mycosis fungoides and Sézary syndrome using flow cytometry: recommendations from the EORTC cutaneous lymphoma task force JJ Scarisbrick, E Hodak, M Bagot, R Stranzenbach, R Stadler, ... European Journal of Cancer 93, 47-56, 2018 | 156 | 2018 |
| Whole-body imaging of lymphovascular niches identifies pre-metastatic roles of midkine D Olmeda, D Cerezo-Wallis, E Riveiro-Falkenbach, PC Pennacchi, ... Nature 546 (7660), 676-680, 2017 | 152 | 2017 |
| Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium P Quaglino, M Maule, HM Prince, P Porcu, S Horwitz, M Duvic, R Talpur, ... Annals of Oncology 28 (10), 2517-2525, 2017 | 140 | 2017 |
| TCR-γ expression in primary cutaneous T-cell lymphomas SM Rodríguez-Pinilla, PL Ortiz-Romero, V Monsalvez, IE Tomás, ... The American journal of surgical pathology 37 (3), 375-384, 2013 | 139 | 2013 |
